Authors:
VANDERSCHUEREN B
DUMON JC
OLEFFE V
HEYMANS C
GERAIN J
BODY JJ
Citation: B. Vanderschueren et al., CIRCULATING CONCENTRATIONS OF INTERLEUKIN-6 IN CANCER-PATIENTS AND THEIR PATHOGENIC ROLE IN TUMOR-INDUCED HYPERCALCEMIA, Cancer immunology and immunotherapy, 39(5), 1994, pp. 286-290
Citation: Scj. Tsai et Gh. Heppner, IMMUNOENDOCRINE MECHANISMS IN MAMMARY-TUMOR PROGRESSION - DIRECT PROLACTIN MODULATION OF PERIPHERAL AND PRENEOPLASTIC HYPERPLASTIC-ALVEOLAR-NODULE-INFILTRATING LYMPHOCYTES, Cancer immunology and immunotherapy, 39(5), 1994, pp. 291-298
Citation: R. Audran et al., INTERACTIONS BETWEEN HUMAN MACROPHAGES AND TUMOR-CELLS IN 3-DIMENSIONAL CULTURES, Cancer immunology and immunotherapy, 39(5), 1994, pp. 299-304
Citation: I. Vollenweider et al., DEVELOPMENT OF 4 DONOR-SPECIFIC PHENOTYPES IN HUMAN LONG-TERM LYMPHOKINE-ACTIVATED KILLER-CELL CULTURES, Cancer immunology and immunotherapy, 39(5), 1994, pp. 305-312
Authors:
OKADA H
YOSHIDA J
SEO H
WAKABAYASHI T
SUGITA K
HAGIWARA M
Citation: H. Okada et al., ANTI-(GLIOMA SURFACE-ANTIGEN) MONOCLONAL-ANTIBODY G-22 RECOGNIZES OVEREXPRESSED CD44 IN GLIOMA-CELLS, Cancer immunology and immunotherapy, 39(5), 1994, pp. 313-317
Authors:
DILAZZARO C
DIGIESI G
TECCE R
LOTTI LV
TORRISI MR
NATALI PG
Citation: C. Dilazzaro et al., IMMUNOTOXINS TO THE HER-2 ONCOGENE PRODUCT - FUNCTIONAL AND ULTRASTRUCTURAL ANALYSIS OF THEIR CYTOTOXIC ACTIVITY, Cancer immunology and immunotherapy, 39(5), 1994, pp. 318-324
Citation: Gl. Ong et al., THE FATE OF ANTIBODIES AND THEIR RADIOLABELS BOUND TO TUMOR-CELLS IN-VITRO - THE EFFECT OF CROSS-LINKING AT THE CELL-SURFACE AND OF ANTIIDIOTYPE ANTIBODIES, Cancer immunology and immunotherapy, 39(5), 1994, pp. 325-331
Authors:
ZENG ZC
TANG ZY
LIU KD
LU JZ
CAI XJ
XIE H
Citation: Zc. Zeng et al., HUMAN ANTI-(MURINE IG) ANTIBODY-RESPONSES IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA RECEIVING INTRAHEPATIC ARTERIAL I-131-LABELED HEPAMA-1 MAB - PRELIMINARY-RESULTS AND DISCUSSION, Cancer immunology and immunotherapy, 39(5), 1994, pp. 332-336
Citation: M. Jackel et al., LACK OF CELL-CYCLE-SPECIFIC EFFECTS OF RECOMBINANT TUMOR-NECROSIS-FACTOR IN-VIVO, Cancer immunology and immunotherapy, 39(5), 1994, pp. 337-341
Citation: G. Stuhler et P. Walden, RECRUITMENT OF HELPER T-CELLS FOR INDUCTION OF TUMOR REJECTION BY CYTOLYTIC T-LYMPHOCYTES, Cancer immunology and immunotherapy, 39(5), 1994, pp. 342-345
Citation: P. Purasiri et al., EFFECT OF ESSENTIAL FATTY-ACIDS ON CIRCULATING T-CELL SUBSETS IN PATIENTS WITH COLORECTAL-CANCER, Cancer immunology and immunotherapy, 39(4), 1994, pp. 217-222
Authors:
SCHEID C
PRENDIVILLE J
JAYSON G
CROWTHER D
FOX B
PETTIT GR
STERN PL
Citation: C. Scheid et al., IMMUNOMODULATION IN PATIENTS RECEIVING INTRAVENOUS BRYOSTATIN-1 IN A PHASE-I CLINICAL-STUDY - COMPARISON WITH EFFECTS OF BRYOSTATIN-1 ON LYMPHOCYTE FUNCTION IN-VITRO, Cancer immunology and immunotherapy, 39(4), 1994, pp. 223-230
Authors:
HUANG SY
SINGH RK
XIE KP
GUTMAN M
BERRY KK
BUCANA CD
FIDLER IJ
BARELI M
Citation: Sy. Huang et al., EXPRESSION OF THE JE MCP-1 GENE SUPPRESSES METASTATIC POTENTIAL IN MURINE COLON-CARCINOMA CELLS/, Cancer immunology and immunotherapy, 39(4), 1994, pp. 231-238
Authors:
SCHOLLER J
STRATEN PT
BIRCK A
SIIM E
DAHLSTROM K
DRZEWIECKI KT
ZEUTHEN J
Citation: J. Scholler et al., ANALYSIS OF T-CELL RECEPTOR-ALPHA-BETA VARIABILITY IN LYMPHOCYTES INFILTRATING MELANOMA PRIMARY TUMORS AND METASTATIC LESIONS, Cancer immunology and immunotherapy, 39(4), 1994, pp. 239-248
Authors:
KURISU H
MATSUYAMA H
OHMOTO Y
SHIMABUKURO T
NAITO K
Citation: H. Kurisu et al., CYTOKINE-MEDIATED ANTITUMOR EFFECT OF BACILLUS-CALMETTE-GUERIN ON TUMOR-CELLS IN-VITRO, Cancer immunology and immunotherapy, 39(4), 1994, pp. 249-253
Authors:
RAGNHAMMAR P
FRODIN JE
TROTTA PP
MELLSTEDT H
Citation: P. Ragnhammar et al., CYTOTOXICITY OF WHITE BLOOD-CELLS ACTIVATED BY GRANULOCYTE-COLONY-STIMULATING FACTOR, GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR AND MACROPHAGE-COLONY-STIMULATING FACTOR AGAINST TUMOR-CELLS IN THE PRESENCE OF VARIOUS MONOCLONAL-ANTIBODIES/, Cancer immunology and immunotherapy, 39(4), 1994, pp. 254-262
Authors:
FIERLBECK G
SCHREINER T
SCHABER B
WALSER A
RASSNER G
Citation: G. Fierlbeck et al., NEUTRALIZING INTERFERON-BETA ANTIBODIES IN MELANOMA PATIENTS TREATED WITH RECOMBINANT AND NATURAL INTERFERON-BETA, Cancer immunology and immunotherapy, 39(4), 1994, pp. 263-268
Citation: Yc. Lee et al., ADJUVANT IMMUNOTHERAPY WITH INTRAPLEURAL STREPTOCOCCUS-PYOGENES (OK-432) IN LUNG-CANCER PATIENTS AFTER RESECTION, Cancer immunology and immunotherapy, 39(4), 1994, pp. 269-274
Citation: D. Kowalczyk et al., DIFFERENT PATTERN OF T-CELL RECEPTOR DELTA-GENE REARRANGEMENT IN TUMOR-INFILTRATING LYMPHOCYTES AND PERIPHERAL-BLOOD IN PATIENTS WITH SOLIDTUMORS, Cancer immunology and immunotherapy, 39(4), 1994, pp. 275-278
Authors:
BERD D
MAGUIRE HC
MASTRANGELO MJ
MURPHY G
Citation: D. Berd et al., ACTIVATION MARKERS ON T-CELLS INFILTRATING MELANOMA METASTASES AFTER THERAPY WITH DINITROPHENYL-CONJUGATED VACCINE, Cancer immunology and immunotherapy, 39(3), 1994, pp. 141-147
Citation: Cm. Fleischmann et al., ENHANCED IN-VIVO SENSITIVITY TO INTERFERON WITH IN-VITRO RESISTANT B16 TUMOR-CELLS IN MICE, Cancer immunology and immunotherapy, 39(3), 1994, pp. 148-154
Citation: M. Tohkin et al., COMPARATIVE-STUDY OF INHIBITORY EFFECTS BY MURINE INTERFERON-GAMMA AND A NEW BISPHOSPHONATE (ALENDRONATE) IN HYPERCALCEMIC, NUDE-MICE BEARING HUMAN TUMOR (LJC-1-JCK), Cancer immunology and immunotherapy, 39(3), 1994, pp. 155-160
Authors:
KATANO M
MATSUO T
MORISAKI T
NAITO K
NAGUMO F
KUBOTA E
NAKAMURA M
HISATSUGU T
TADANO J
Citation: M. Katano et al., INCREASED PROLIFERATION OF A HUMAN BREAST-CARCINOMA CELL-LINE BY RECOMBINANT INTERLEUKIN-2, Cancer immunology and immunotherapy, 39(3), 1994, pp. 161-166
Authors:
CLEMENTI E
BUCCI E
CITTERIO G
LANDONIO G
CONSOGNO G
FORTIS C
Citation: E. Clementi et al., REVERSIBLE ANERGY IN CIRCULATING LYMPHOCYTES OF CANCER-PATIENTS DURING INTERLEUKIN-2 THERAPY, Cancer immunology and immunotherapy, 39(3), 1994, pp. 167-171